Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOP”

Showing 9 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05090891
What this trial is testing

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Incyte Corporation 98
Not applicableStudy completedNCT02066324
What this trial is testing

Urine Sample Collection From FOP Patients

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT02322255
What this trial is testing

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 114
Testing effectiveness (Phase 2)Study completedNCT03188666
What this trial is testing

Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals 44
Not applicableLooking for participantsNCT02745158
What this trial is testing

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
The International FOP Association 800
Early research (Phase 1)Study completedNCT05099445
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Who this might be right for
Renal ImpairmentHemodialysis
Incyte Corporation 48
Testing effectiveness (Phase 2)Ended earlyNCT05039515
What this trial is testing

Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 113
Not applicableTemporarily Not AvailableNCT07301450
What this trial is testing

An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02279095
What this trial is testing

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 58

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation